My Top Growth Stock to Buy in November
I don't like the term "growth stock" all that much. Investors want their money to grow in some shape, form, or fashion with every stock they buy. However, I understand that textbook growth stocks generate market-beating growth that not every stock will deliver.
And I do have several favorite stocks that fit that description. My top growth stock to buy in November is one that I've owned for several years and believe will handily outperform the market over the long term.
Image source: Vertex Pharmaceuticals.
Source Fool.com
Vertex Pharmaceuticals Inc. Aktie
387,85 €
-0,18 %
Die Vertex Pharmaceuticals Inc. Aktie steht ausgezeichnet da: Nur Buy-Einschätzungen und keine Sell-Einschätzungen.
Mit einem Kursziel von 464 € für Vertex Pharmaceuticals Inc. ist ein leichter Anstieg gegenüber dem aktuellen Kurs von 387.85 € zu erwarten.
